Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response
By
- AMS
posted
Dec 04, 2020 06:34 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Dupilumab as promising treatment for prurigo nodularis: current evidences
- AMS
Added Feb 16, 2021
Blog Entry
Response: Management challenges in prurigo nodularis
- AMS
Added Feb 21, 2020
Blog Entry
Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis
- AMS
Added Jul 26, 2021
Blog Entry
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines
- AMS
Added Feb 22, 2021
Blog Entry
Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis
- AMS
Added Jul 09, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic